Global Information
회사소개 | 문의 | 위시리스트

라틴아메리카의 감염증 검사 시장 분석(아르헨티나, 브라질, 콜롬비아, 멕시코, 페루) : 매출액 예측과 경쟁 전략

Latin America Virology and Bacteriology Testing Market, 2019-2023: A 7-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Forecasts, Technology and Instrumentation Review

리서치사 Venture Planning Group
발행일 상품 코드 368982
페이지 정보 영문 975 Pages
가격
US $ 3,750 ₩ 4,596,000 DataPack (Local License)
US $ 7,500 ₩ 9,192,000 PDF by E-mail (Local license)
US $ 9,800 ₩ 12,011,000 PDF by E-mail (Global License)


라틴아메리카의 감염증 검사 시장 분석(아르헨티나, 브라질, 콜롬비아, 멕시코, 페루) : 매출액 예측과 경쟁 전략 Latin America Virology and Bacteriology Testing Market, 2019-2023: A 7-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Forecasts, Technology and Instrumentation Review
발행일 : 페이지 정보 : 영문 975 Pages

라틴아메리카 국가(아르헨티나, 브라질, 콜롬비아, 멕시코, 페루)의 감염증 검사(Infectious Disease Testing) 관련 시장을 분석했으며, 검사 대상의 주요 감염증과 검사 방법, 시장 전체 동향과 시장 규모 전망(향후 5년간 예측), 현재 이용중·개발중인 검사기기 및 시약 개요, 각국 시장의 구조와 동향, 주요 기존·신규 진출 기업 프로파일 등의 정보를 전해드립니다.

제1장 서론

제2장 세계 시장 및 기술 개요

  • 주요 감염증 검사(총 68종)
    • 에이즈(AIDS)
    • 아데노바이러스
    • 아에로모나스
    • 탄저병/탄저균
    • 아르보바이러스
    • 바베시아증
    • 간균성 유상피세포혈관증(BEA)
    • 블라스토시스티스 호미니스
    • 브루셀라균
    • 캄필로박터
    • 칸디다
    • 샤가스병
    • 연성하감
    • 클라미디아
    • 클로스트리듐 디피실리균
    • 코로나바이러스
    • 쿡사키 바이러스
    • 크로츠펠트 야콥병
    • 크립토스포리디움 파븀
    • Cyclospora Cayetanensis
    • 거대세포바이러스
    • 에볼라 바이러스
    • 대장균
    • 에코바이러스
    • 뇌염
    • 장염 바이러스
    • 엡스타인바 바이러스
    • 람블편모충
    • 임질
    • 서혜부 육아종
    • 한타 바이러스
    • 헬리코박터 파일로리
    • 간염
    • 단순 포진 바이러스
    • Human Herpes Virus-6(HHV-6)
    • 인플루엔자 바이러스
    • 레지오넬라
    • 라임병
    • 서혜 림프 육아종(LGV)
    • 말라리아
    • 홍역
    • 수막염
    • 미포자충류
    • 단핵증
    • 유행성 이하선염
    • 마이코플라즈마
    • 유두종 바이러스
    • 파보바이러스 B19
    • 폐렴
    • 폴리오마 바이러스
    • 녹농균
    • 광견병
    • 호흡기세포융합바이러스(RSV)
    • 라이노바이러스
    • 로타바이러스
    • 풍진
    • 살모넬라균
    • 패혈증
    • 세균성 적리
    • 황색 포도상구균
    • 연쇄구균
    • 매독
    • 주혈원충병
    • 질편모충
    • 결핵
    • 비브리오
    • 웨스트 나일 바이러스
    • 예르시니아
  • 검사 장비 분석 : 주요 자동/반자동 분석기의 조작상 특징, 기능, 판매 가격
  • 신규 진단 기술
    • 분자진단
    • 단일클론항체
    • 면역분석법(Immunoassays)
    • Differential Light Scattering
    • 정보기술(IT)
    • 인공지능
    • 리포솜
    • 유세포 분석(Flow Cytometry)
    • 크로마토그래피
    • 영상진단
    • Gel Microdroplets
    • 기타

제3장 아르헨티나 : 시장 규모, 성장률, 매출 예측 : 검사 항목별

제4장 브라질

제5장 콜롬비아

제6장 멕시코

제7장 페루

제8장 주요 제품 개발 기회

  • 검사 장비
  • 시약 키트와 검사 시스템/패널
  • 정보기술(IT)
  • 보조 제품

제9장 분산형 검사 제품 설계 기준

제10장 대체적인 시장 보급 전략

  • 내부 개발
  • 합작투자 협정
  • 대학과의 계약
  • 분산형 검사 시장의 유통 전략
    • 마케팅 방식
    • 제품의 복잡성
    • 고객 선호
    • 기존 공급업체
    • 신규 공급업체
    • 유통업체의 주요 유형
    • 시장 세분화

제11장 잠재적인 시장 진출 장벽과 위험

  • 시장의 성숙화
  • 비용 억제
  • 경쟁
  • 최첨단 기술과 한계
  • 특허 보호
  • 규제에 의한 억제
  • 분산형 검사 시장이 해결해야 할 과제

제12장 경쟁사 평가

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics/Grifols
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio Inc.
  • Thermo Fisher
  • Wallac/PE
  • Wako

도표

LSH 16.10.11

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

This new report from LeadingMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The report provides granular market segmentation analysis and forecasts for over 100 microbiology tests; profiles leading suppliers and recent market entrants with innovative technologies and products; reviews current instrumentation; evaluates emerging technologies; and offers specific opportunities and strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Carbapenemase, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes, Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Norovirus, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Country Analyses

Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela

Market Segmentation Analysis

- Sales and market shares of major suppliers of infectious disease diagnostic products in major countries by test.

- Test and sales forecasts for 100 infectious disease diagnostic assays by country, individual test and market segment:

- Review of market dynamics, trends, structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of emerging diagnostic technologies and their potential applications for infectious disease testing.

- Companies developing or marketing infectious disease diagnostic products by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Opportunities and Strategies for Suppliers

- Emerging opportunities for new instrumentation, reagent systems, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 975 pages and 137 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Major Infectious Disease Tests
    • 1. AIDS
    • 2. Adenovirus
    • 3. Aeromonas
    • 4. Anthrax/Bacillus Anthracis
    • 5. Arboviruses
    • 6. Babesiosis
    • 7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
    • 8. Blastocystis Hominis
    • 9. Brucella
    • 10. Campylobacter
    • 11. Candida
    • 12. Chagas Disease
    • 13. Chancroid
    • 14. Chlamydia
    • 15. Clostridium Difficile
    • 16. Coronaviruses
    • 17. Coxsackieviruses
    • 18. Creutzfeldt-Jakob's Disease
    • 19. Cryptosporidium Parvum
    • 20. Cyclospora Cayetanensis
    • 21. Cytomegalovirus
    • 22. Ebola Virus
    • 23. E. Coli
    • 24. EchoVirus
    • 25. Encephalitis
    • 26. Enteroviruses
    • 27. Epstein-Barr Virus
    • 28. Giardia Lamblia
    • 29. Gonorrhea
    • 30. Granuloma Inguinale
    • 31. Hantavirus
    • 32. Helicobacter Pylori
    • 33. Hepatitis
    • 34. Herpes Simplex Virus
    • 35. Human Herpes Virus-6 (HHV-6)
    • 36. Influenza Viruses
    • 37. Legionella
    • 38. Lyme Disease
    • 39. Lymphogranuloma Venereum (LGV)
    • 40. Malaria
    • 41. Measles (Rubeola)
    • 42. Meningitis
    • 43. Microsporidium
    • 44. Mononucleosis
    • 45. Mumps
    • 46. Mycoplasma
    • 47. Papillomaviruses
    • 48. Parvovirus B19
    • 49. Pneumonia
    • 50. Polyomaviruses
    • 51. Pseudomonas Aeruginosa
    • 52. Rabies
    • 53. Respiratory Syncytial Virus (RSV)
    • 54. RhinoViruses
    • 55. RotaVirus (REOVIRUS)
    • 56. Rubella(MEASLES)
    • 57. Salmonellosis
    • 58. Septicemia
    • 59. Shigellosis
    • 60. Staphylococcus Aureus
    • 61. Streptococci
    • 62. Syphilis
    • 63. Toxoplasmosis
    • 64. Trichomonas Vaginalis
    • 65. Tuberculosis
    • 66. Vibrio
    • 67. West Nile Virus
    • 68. Yersina
  • B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Automated and Semiautomated Analyzers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

III. Argentina: Market Size, Growth and Sales Forecasts by Test

IV. Brazil: Market Size, Growth and Sales Forecasts by Test

V. Colombia: Market Size, Growth and Sales Forecasts by Test

VI. Mexico: Market Size, Growth and Sales Forecasts by Test

VII. Peru: Market Size, Growth and Sales Forecasts by Test

VIII. Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Information Technology
  • D. Auxiliary Products

IX. Design Criteria for Decentralized Testing Products

X. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

XI. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

XII. Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics/Grifols
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Bartonella Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Clostridium Tests
  • Major Companies Developing or Marketing Coronavirus Tests
  • Major Companies Developing or Marketing Cryptosporidium Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Echovirus Tests
  • Major Companies Developing or Marketing Enterovirus Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Giardia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Hantavirus Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Lymphogranuloma Tests
  • Major Companies Developing or Marketing Malaria Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing MeningitisTests
  • Major Companies Developing or Marketing Microsporidium Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Papilloma Virus Tests
  • Major Companies Developing or Marketing Parvovirus Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Septicemia Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Staphylococci Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Toxoplasmosis Tests
  • Major Companies Developing or Marketing Trichomonas Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Major Companies Developing or Marketing West Nile Tests
  • Major Companies Developing or Marketing Yersinia Tests
  • Argentina
  • All Market Segments Infectious Disease Test Volume Forecast
  • Argentina
  • All Market Segments Infectious Disease Test Volume by Method
  • Argentina
  • All Market Segments Infectious Disease Diagnostics
  • Market Forecast
  • Argentina
  • HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast
  • Forecast
  • Argentina
  • HIV Ag Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Western Blot/Other Confirmatory Test Volume and
  • Diagnostics Sales Forecast
  • Argentina
  • Adenovirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Aeromonads Test Volume and Diagnostics Sales Forecast
  • Argentina
  • BEA Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Blastocystis Hominis Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Campylobacter Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Candida Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Chancroid Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Chlamydia Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Clostridium Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Coronavirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Coxsackievirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Cryptosporidium Test Volume and Diagnostics Sales Forecast
  • Argentina
  • CMV Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Cyclospora Test Volume and Diagnostics Sales Forecast
  • Argentina
  • E. Coli Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Echovirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Encephalitis Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Enterovirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • EBV Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Giardia Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Gonorrhea Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Granuloma Inguinale Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Hantavirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Helicobacter Pylori Test Volume and Diagnostics Sales Forecast
  • Argentina
  • HBsAg Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Hepatitis C Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Anti-HBc Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Anti-HBs Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Anti-HAV Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Hepatitis Delta Test Volume and Diagnostics Sales Forecast
  • Argentina
  • HAV NAT Test Volume and Diagnostics Sales Forecast
  • Argentina
  • HBV NAT Test Volume and Diagnostics Sales Forecast
  • Argentina
  • HBcAg Test Volume and Diagnostics Sales Forecast
  • Argentina
  • HBeAg Test Volume and Diagnostics Sales Forecast
  • Argentina
  • ALT/SGPT Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast
  • Argentina
  • HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Influenza Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Legionella Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Lyme Disease Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Lymphogranuloma Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Malaria Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Measles Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Meningitis Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Microsporidium Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Mononucleosis Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Mumps Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Mycoplasma Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Papilloma Virus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Parvovirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Pneumonia Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Polyoma Viruses Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Pseudomonas Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Rabies Test Volume and Diagnostics Sales Forecast
  • Argentina
  • RSV Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Rhinovirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Rotavirus Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Rubella Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Salmonella Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Septicemia Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Shigella Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Staphylococci Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Streptococci Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Syphilis Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Toxoplasmosis Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Trichomonas Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Tuberculosis Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Vibrio Test Volume and Diagnostics Sales Forecast
  • Argentina
  • Yersinia Test Volume and Diagnostics Sales Forecast
  • Brazil
  • All Market Segments Infectious Disease Test Volume Forecast
  • Brazil
  • All Market Segments Infectious Disease Test Volume by Method
  • Brazil
  • All Market Segments Infectious Disease Test Volume by Method
  • Brazil
  • All Market Segments Infectious Disease Diagnostics Market Forecast
  • Brazil
  • HIV or HIV I/HIVII Test Volume and Diagnostics Sales
  • Forecast
  • Brazil
  • HIV Ag Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Adenovirus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Aeromonads Test Volume and Diagnostics Sales Forecast
  • Brazil
  • BEA Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Blastocystis Hominis Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Campylobacter Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Candida Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Chancroid Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Chlamydia Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Clostridium Test Volume and Diagnostics Sales Forecast
  • Brazil
  • CoxsackieVirus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Cryptosporidium Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Cyclospora Test Volume and Diagnostics Sales Forecast
  • Brazil
  • CMV Test Volume and Diagnostics Sales Forecast
  • Brazil
  • E. Coli Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Echovirus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Encephalitis Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Enterovirus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • EBV Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Giardia Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Gonorrhea Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Granuloma Inguinale Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Hantavirus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Helicobacter Pylori Test Volume and Diagnostics Sales Forecast
  • Brazil
  • HAV NAT Test Volume and Diagnostics Sales Forecast
  • Brazil
  • HBV NAT Test Volume and Diagnostics Sales Forecast
  • Brazil
  • HBsAg Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Hepatitis C Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Anti-HBc Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Anti-HBs Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Anti-HAV Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Hepatitis Delta Test Volume and Diagnostics Sales Forecast
  • Brazil
  • HBcAg Test Volume and Diagnostics Sales Forecast
  • Brazil
  • HBeAg Test Volume and Diagnostics Sales Forecast
  • Brazil
  • ALT/SGPT Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast
  • Brazil
  • HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Influenza Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Legionella Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Lyme Disease Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Lymphogranuloma Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Malaria Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Measles Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Meningitis Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Microsporidium Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Mononucleosis Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Mumps Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Mycoplasma Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Papilloma Virus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Parvovirus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Pneumonia Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Polyoma Viruses Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Pseudomonas Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Rabies Test Volume and Diagnostics Sales Forecast
  • Brazil
  • RSV Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Rhinovirus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Rotavirus Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Rubella Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Salmonella Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Septicemia Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Shigella Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Staphylococci Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Streptococci Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Syphilis Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Toxoplasmosis Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Trichomonas Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Tuberculosis Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Vibrio Test Volume and Diagnostics Sales Forecast
  • Brazil
  • West Nile Test Volume and Diagnostics Sales Forecast
  • Brazil
  • Yersinia Test Volume and Diagnostics Sales Forecast
  • Colombia
  • All Market Segments Infectious Disease Test Volume Forecast
  • Colombia
  • All Market Segments Infectious Disease Test Volume by Method
  • Colombia
  • All Market Segments Infectious Disease Diagnostics Market Forecast
  • Colombia
  • HIV or HIV I/HIVII Test Volume and Diagnostics Sales Forecast
  • Colombia
  • HIVAg Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Adenovirus Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Aeromonads Test Volume and Diagnostics Sales Forecast
  • Colombia
  • BEA Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Blastocystis Hominis Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Campylobacter Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Candida Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Chancroid Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Chlamydia Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Clostridium Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Coxsackievirus Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Cryptosporidium Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Clyclospora Test Volume and Diagnostics Sales Forecast
  • Colombia
  • CMV Test Volume and Diagnostics Sales Forecast
  • Colombia
  • E. Coli Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Echovirus Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Ecephalitis Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Enterovirus Test Volume and Diagnostics Sales Forecast
  • Colombia
  • EBV Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Giardia Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Gonorrhea Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Granuloma Inguinale Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Helicobacter Pylori Test Volume and Diagnostics Sales Forecast
  • Colombia
  • HAV NAT Test Volume and Diagnostics Sales Forecast
  • Colombia
  • HBV NAT Test Volume and Diagnostics Sales Forecast
  • Colombia
  • HBsAg Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Hepatitis C Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Anti-HBC Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Anti-HBS Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Anti-HAV Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Hepatitis Delta Test Volume and Diagnostics Sales Forecast
  • Colombia
  • HBcAg Test Volume and Diagnostics Sales Forecast
  • Colombia
  • HBeAg Test Volume and Diagnostics Sales Forecast
  • Colombia
  • ALT/SGPT Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast
  • Colombia
  • HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Influenza Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Legionella Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Lyme Disease Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Lymphogranuloma Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Malaria Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Measles Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Meningitis Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Microsporidium Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Mononucleosis Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Mumps Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Mycoplasma Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Papilloma Virus Test Volume and Diagnostics Sales Forecast
  • Colombia
  • ParvoVirus B19 Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Pneumonia Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Polyoma Viruses Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Pseudomonas Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Rabies Test Volume and Diagnostics Sales Forecast
  • Colombia
  • RSV Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Rhinovirus Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Rotavirus Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Rubella Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Salmonella Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Septicemia Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Shigella Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Staphylococci Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Streptococci Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Syphilis Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Toxoplasmosis Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Trichomonas Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Tuberculosis Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Vibrio Test Volume and Diagnostics Sales Forecast
  • Colombia
  • West Nile Test Volume and Diagnostics Sales Forecast
  • Colombia
  • Yersinia Test Volume and Diagnostics Sales Forecast
  • Mexico
  • All Market Segments Infectious Disease Test Volume Forecast
  • Mexico
  • All Market Segments Infectious Disease Test Volume by Method
  • Mexico
  • All Market Segments Infectious Disease Diagnostics Market Forecast
  • Mexico
  • HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast
  • Mexico
  • HIVAg Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Adenovirus Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Aeromonads Test Volume and Diagnostics Sales Forecast
  • Mexico
  • BEA Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Blastocystis Hominis Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Campylobacter Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Candida Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Chancroid Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Chlamydia Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Clostridium Test Volume and Diagnostics Sales Forecast
  • Mexico
  • CoxsackieVirus Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Cryptosporidium Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Cyclospora Test Volume and Diagnostics Sales Forecast
  • Mexico
  • CMV Test Volume and Diagnostics Sales Forecast
  • Mexico
  • E. Coli Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Echovirus Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Encephalitis Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Enterovirus Test Volume and Diagnostics Sales Forecast
  • Mexico
  • EBV Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Giardia Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Gonorrhea Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Helicobacter Pylori Test Volume and Diagnostics Sales Forecast
  • Mexico
  • HAV NAT Test Volume and Diagnostics Sales Forecast
  • Mexico
  • HBV NAT Test Volume and Diagnostics Sales Forecast
  • Mexico
  • HbsAg Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Hepatitis C Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Anti-HBc Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Anti-HBs Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Anti-HAV Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Hepatitis Delta Test Volume and Diagnostics Sales Forecast
  • Mexico
  • HBcAg Test Volume and Diagnostics Sales Forecast
  • Mexico
  • HBeAg Test Volume and Diagnostics Sales Forecast
  • Mexico
  • ALT/SGPT Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast
  • Mexico
  • HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Influenza Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Legionella Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Lyme Disease Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Lymphogranuloma Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Malaria Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Measles Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Meningitis Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Microsporidium Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Mononucleosis Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Mumps Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Mycoplasma Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Papilloma Virus Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Parvovirus Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Pneumonia Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Polyomaviruses Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Pseudomonas Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Rabies Test Volume and Diagnostics Sales Forecast
  • Mexico
  • RSV Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Rhinovirus Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Rotavirus Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Rubella Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Salmonella Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Septicemia Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Shigella Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Staphylococci Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Streptococci Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Syphilis Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Toxoplasmosis Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Trichomonas Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Tuberculosis Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Vibrio Test Volume and Diagnostics Sales Forecast
  • Mexico
  • West Nile Test Volume and Diagnostics Sales Forecast
  • Mexico
  • Yersinia Test Volume And Diagnostics Sales Forecast
  • Peru
  • All Market Segments Infectious Disease Test Volume Forecast
  • Peru
  • All Market Segments Infectious Disease Test Volume by Method
  • Peru
  • All Market Segments Infectious Disease Diagnostics Market Forecast
  • Peru
  • HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast
  • Peru
  • HIVAg Test Volume and Diagnostics Sales Forecast
  • Peru
  • Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast
  • Peru
  • Adenovirus Test Volume and Diagnostics Sales Forecast
  • Peru
  • Aeromonads
  • Test Volume and Diagnostics Sales Forecast
  • Peru BEA Test Volume and Diagnostics Sales Forecast
  • Peru
  • Blastocystis Hominis Test Volume and Diagnostics Sales Forecast
  • Peru
  • Campylobacter
  • Test Volume and Diagnostics Sales Forecast
  • Peru
  • Candida
  • Test Volume and Diagnostics Sales Forecast
  • Peru
  • Chancroid
  • Test Volume and Diagnostics Sales Forecast
  • Peru
  • Chlamydia Test Volume and Diagnostics Sales Forecast
  • Peru
  • Clostridium Test Volume and Diagnostics Sales Forecast
  • Peru
  • Coronavirus Test Volume and Diagnostics Sales Forecast
  • Peru
  • CoxsackieVirus Test Volume and Diagnostics Sales Forecast
  • Peru
  • Cryptosporidium Test Volume and Diagnostics Sales Forecast
  • Peru
  • Cyclospora Test Volume and Diagnostics Sales Forecast
  • Peru
  • CMV Test Volume and Diagnostics Sales Forecast
  • Peru
  • E. Coli Test Volume and Diagnostics Sales Forecast
  • Peru
  • Echovirus Test Volume and Diagnostics Sales Forecast
  • Peru
  • Encephalitis Test Volume and Diagnostics Sales Forecast
  • Peru
  • Enterovirus Test Volume and Diagnostics Sales Forecast
  • Peru
  • EBV Test Volume and Diagnostics Sales Forecast
  • Peru
  • Giardia Test Volume and Diagnostics Sales Forecast
  • Peru
  • Gonorrhea Test Volume and Diagnostics Sales Forecast
  • Peru
  • Granuloma Inguinale Test Volume and Diagnostics Sales Forecast
  • Peru
  • Helicobacter Pylori Test Volume and Diagnostics Sales Forecast
  • Peru
  • HAV NAT Test Volume and Diagnostics Sales Forecast
  • Peru
  • HBV NAT Test Volume and Diagnostics Sales Forecast
  • Peru
  • HbsAg Test Volume and Diagnostics Sales Forecast
  • Peru
  • Hepatitis C Test Volume and Diagnostics Sales Forecast
  • Peru
  • Anti-HBc Test Volume and Diagnostics Sales Forecast
  • Peru
  • Anti-HBs Test Volume and Diagnostics Sales Forecast
  • Peru
  • Anti-HAV Test Volume and Diagnostics Sales Forecast
  • Peru
  • Hepatitis Delta Test Volume and Diagnostics Sales Forecast
  • Peru
  • HBcAg Test Volume and Diagnostics Sales Forecast
  • Peru
  • HBeAg Test Volume and Diagnostics Sales Forecast
  • Peru
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast
  • Peru
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast
  • Peru
  • HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast
  • Peru
  • Influenza Test Volume and Diagnostics Sales Forecast
  • Peru
  • Legionella Test Volume and Diagnostics Sales Forecast
  • Peru
  • Lyme Disease Test Volume and Diagnostics Sales Forecast
  • Peru
  • Lymphogranuloma Test Volume and Diagnostics Sales Forecast
  • Peru
  • Malaria Test Volume and Diagnostics Sales Forecast
  • Peru
  • Measles Test Volume and Diagnostics Sales Forecast
  • Peru
  • Meningitis Test Volume and Diagnostics Sales Forecast
  • Peru
  • Microsporidium Test Volume and Diagnostics Sales Forecast
  • Peru
  • Mononucleosis Test Volume and Diagnostics Sales Forecast
  • Peru
  • Mumps Test Volume and Diagnostics Sales Forecast
  • Peru
  • Mycoplasma Test Volume and Diagnostics Sales Forecast
  • Peru
  • Papilloma Virus Test Volume and Diagnostics Sales Forecast
  • Peru
  • Parvovirus Test Volume and Diagnostics Sales Forecast
  • Peru
  • Pneumonia Test Volume and Diagnostics Sales Forecast
  • Peru
  • Polyomaviruses Test Volume and Diagnostics Sales Forecast
  • Peru
  • Pseudomonas Test Volume and Diagnostics Sales Forecast
  • Peru
  • Rabies Test Volume and Diagnostics Sales Forecast
  • Peru
  • RSV Test Volume and Diagnostics Sales Forecast
  • Peru
  • Rhinovirus Test Volume and Diagnostics Sales Forecast
  • Peru
  • Rotavirus Test Volume and Diagnostics Sales Forecast
  • Peru
  • Rubella Test Volume and Diagnostics Sales Forecast
  • Peru
  • Salmonella Test Volume and Diagnostics Sales Forecast
  • Peru
  • Septicemia Test Volume and Diagnostics Sales Forecast
  • Peru
  • Shigella Test Volume and Diagnostics Sales Forecast
  • Peru
  • Staphylococci Test Volume and Diagnostics Sales Forecast
  • Peru
  • Streptococci Test Volume and Diagnostics Sales Forecast
  • Peru
  • Syphilis Test Volume and Diagnostics Sales Forecast
  • Peru
  • Toxoplasmosis Test Volume and Diagnostics Sales Forecast
  • Peru
  • Trichomonas Test Volume and Diagnostics Sales Forecast
  • Peru
  • Tuberculosis Test Volume and Diagnostics Sales Forecast
  • Peru
  • Vibrio Test Volume and Diagnostics Sales Forecast
  • Peru
  • West Nile Test Volume and Diagnostics Sales Forecast
  • Peru
  • Yersinia Test Volume and Diagnostics Sales Forecast
Back to Top
전화 문의
F A Q